Page 27 - Sun Resources Annual Report 2013

Damian Kestel
B.Com and B.Laws (Hons)
Non-Executive and Independent Director
Experience and expertise
Mr Kestel was appointed to the Board on 1 February
2012 as Non-Executive Director. Mr Kestel has over 15
years research, sales and management experience in
Asian equity capital markets, most recently with CLSA
Asia-Pacific Markets for ten years, to whom he remains
a consultant. He holds a Bachelor of Law degree with
Honours from the University of Adelaide, a Bachelor of
Commerce degree from the University of Western Australia
and a Graduate Diploma in Securities and Investment from
the Australian Securities Institute.
Other current directorships
None.
Former directorships in the last three years
None.
Special responsibilities
Member of Audit Committee (from 30 April 2013).
Member of Remuneration Committee (from 30 April 2013).
Interests in shares and options
Mr Kestel holds 18,216,368 fully paid ordinary shares and
5,000,000 unlisted options in the Company.
Philip Linsley
B.Sc (Hons Geol), Ph.D, MBA. Non-Executive
Non-Executive and Independent Director
Experience and expertise
Dr Linsley was appointed to the Board on 7 May 1997.
Dr Linsley is a geologist whose primary role was to
assist the Board in the acquisition of oil production and
to investigate exploration opportunities outside Australia
and Oceania. His career developed initially in employment
with Texaco and Mesa and later as a consultant working
mainly on acquisitions and disposals. Dr Linsley retired as
a Director on 30 June 2013.
Other current directorships
Dr Linsley is a Director of PXP Management Limited, a
United Kingdom based consultancy firm focusing on the
oil and gas exploration and production in many parts of
the world (Australia, South East Asia, Africa, America,
Kazakhstan, Europe and the Middle East).
Former directorships in the last three years
None.
Special responsibilities
Member of the Audit Committee (to 30 June 2013).
Member of the Remuneration Committee (to 30 June
2013).
Interests in shares and options
Dr Linsley and family hold 5,124,383 fully paid ordinary
shares and 5,000,000 unlisted options in the Company.
DIRECTORS’ REPORT 25